Funding for this research was provided by:
Shire Pharmaceutical Development Limited
National Institute for Health Research (NIHR) Imperial Biomedical Research Centre
Text and Data Mining valid from 2018-06-25
Received: 27 November 2017
Accepted: 13 June 2018
First Online: 25 June 2018
Ethics approval and consent to participate
: Research was performed in accordance with the Declaration of Helsinki and was approved by the Scottish Prison Service Research Access and Ethics Committee (reference: 7/13/10/10). Written consent to participate was received from each prisoner.
: Not applicable
: SY has received honoraria for consultancy, travel, educational talks and/or research from Janssen, Eli Lilly, HB Pharma, and/or Shire. MF consulted for Amgen, CSL Behring, Merck, Novo Nordisk, Shire, and Vertex. GG and RG have no conflicts of interest. PH was an employee of Shire working on ADHD projects from 2009 to 2013. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Aside from KK, none of the authors received funds for their involvement in this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.